ProSomnus, Inc. (OSA)
NASDAQ: OSA · IEX Real-Time Price · USD
0.569
-0.047 (-7.67%)
At close: Mar 28, 2024, 4:00 PM
0.552
-0.017 (-3.08%)
After-hours: Mar 28, 2024, 5:27 PM EDT
Company Description
ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea.
The company sells its products to sleep dentists, sleep physicians, primary care providers, otolarygologists, and other integrated healthcare service providers through a direct sales force.
ProSomnus, Inc. is headquartered in Pleasanton, California.
ProSomnus, Inc.
Country | United States |
Founded | 2016 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 129 |
CEO | Leonard Liptak |
Contact Details
Address: 5675 Gibraltar Dr Pleasanton, California 94588 United States | |
Phone | 844-537-5337 |
Website | prosomnus.com |
Stock Details
Ticker Symbol | OSA |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001934064 |
ISIN Number | US50535E1082 |
Employer ID | 88-2978216 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Leonard Liptak | Co-Founder, Chief Executive Officer and Director |
Sung Kim | Co-Founder and Chief Technology Officer |
Laing F. Rikkers | Co-founder and Executive Chairman |
Brian B. Dow | Chief Financial Officer |
Dr. John E. Remmers M.D. | Chief Scientist |
Heather Whalen | Vice President of Global Marketing Services |
Dr. Shouresh Charkhandeh D.D.S. | Global Scientific Committee Chair |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 27, 2024 | 10-K | Annual Report |
Mar 26, 2024 | 8-K | Current Report |
Mar 22, 2024 | 8-K | Current Report |
Feb 16, 2024 | 8-K | Current Report |
Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Feb 13, 2024 | EFFECT | Notice of Effectiveness |
Feb 13, 2024 | EFFECT | Notice of Effectiveness |
Feb 13, 2024 | POS AM | Post-Effective amendments for registration statement |
Feb 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Feb 5, 2024 | POS AM | Post-Effective amendments for registration statement |